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Abstract
In longitudinal studies, continuous, binary, categorical, and survival outcomes are often jointly collected,
possibly with some observations missing. However, when it comes to modeling responses, the ordinal
ones have received less attention in the literature. In a longitudinal or hierarchical context, the univariate
proportional odds mixed model (POMM) can be regarded as an instance of the generalized linear mixed
model (GLMM). When the response of the joint multivariate model encompass ordinal responses, the
complexity further increases. An additional problem of model fitting is the size of the collected data.
Pseudo-likelihood based methods for pairwise fitting, for partitioned samples and, as introduced in this
paper, pairwise fitting within partitioned samples allow joint modeling of even larger numbers of
responses. We show that that pseudo-likelihood methodology allows for highly efficient and fast
inferences in high-dimensional large datasets.
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pairwise fitting, sample partition, asymptotic relative efficiency, reduced computation time
1 Introduction
Many statistical models have been developed for analyzing longitudinal data. Most of them are
limited to the analysis of a single outcome, measured repeatedly over time. The random-eﬀect
approach has been very popular for several decades. The introduction of linear mixed models
(LMM) for continuous data by Laird and Ware1 was extended to generalized linear mixed
models (GLMM) for non-continuous data by Breslow and Clayton,2 Wolﬁnger and O’Connell,3
and Engel and Keen.4 Multinomial (nominal and ordinal) data can be regarded as a special case of
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non-continuous data. Some examples of models for the latter data type can be found in the
literatures,5–7 such as the proportional odds mixed model (POMM) described by Agresti and Lang.5
Very often the collected outcomes are considered not as separate endpoints, but as components in
a joint one. For example, in a diabetes study, one can model the body mass index and cholesterol
level collected repeatedly from the same patient. Joint modeling will be the preferable technique
because every outcome may have its own covariate structure as random eﬀect, and at the same time
the association between the outcomes can be captured in terms of the correlation between random
eﬀects.
Another feature of longitudional studies is the diversity in data type: continuous, binary, ordinal,
survival data could be jointly collected and chosen to be jointly modelled. In the literature, a wide
variety of joint modeling techniques can be found. For example, Morrell et al.8 considered three
continuous responses for screening prostate data, and further used the outcome for classiﬁcation
purposes. Gueorguieva9 considered the joint modeling of continuous-binary measures in a toxicity
study of pregnant/non-pregnant mice. Iddi and Molenberghs10 considered the joint modeling of a
continuous visual activity outcome and a binary vision-loss outcome in an age-related macular
degeneration study. These authors also considered two binary longitudinal outcomes: the number
of positive HCV and HIV cases in serological data. There also exist many approaches for the joint
modeling of longitudinal and survival data (e.g. Rizopoulos11). For an excellent relatively early
review, we refer to the work of Tsiatis and Davidian.12 Molenberghs and Verbeke13 discuss a
number of techniques that jointly model outcomes of diﬀerent types. But the advent of larger
data storage facilities led to an additional complication: high-dimensional data, calling for a
solution for large and/or complex data.
To address the problem of computational complexity when jointly modeling random eﬀects in the
high-dimensional case, Fieuws and Verbeke14 suggested a bivariate pairwise approach using pseudo-
likelihood. The method was illustrated in a joint analysis of 22 longitudinally measured outcomes.
Since then, the technique has been applied to binary data15 and to a combination of continuous and
binary data.16 This method is also reviewed by Molenberghs and Verbeke13 (chap. 24). Molenberghs
et al.17 went on to propose a method to solve the problem of large data by partitioning into
subsamples that are analyzed separately and by combining the obtained inferences into a single
one. Two diﬀerent scenarios were considered: independent and dependent partitioning. It was shown
that, to achieve high relative eﬃciency for small samples, the data should be divided into subsamples
such that the size of subsamples is much larger than the number of subsamples. In general, the
number of subsamples for splitting depends on the pertinent setting of the modeling such as length
of the sequence of longitudinal data and the complexity of the model such as the number of ﬁxed
eﬀects on the one hand and the dimensionality of the random eﬀects on the other hand.
In Vasdekis et al.,18 a weighted pairwise likelihood estimation method was proposed based on
estimates obtained from separate maximizations of marginal pairwise likelihoods. The weighted
estimator is found to be more eﬃcient than the one that assumes all weights to be equal.
In this work, we investigate the performance of both pairwise- and partition ﬁtting on ordinal
data. In addition, we develop a new approach in multivariate joint modeling based on pseudo-
likelihood: we introduce the pairwise ﬁtting within independent subsamples and combine the
obtained inferences. The proposed method is based on the asymptotic inference of the parameter
estimates and can be applied to every type of data. When modeling hierarchical ordinal responses,
the complexity increases dramatically. Hence, the value of our method becomes even more
signiﬁcant.
We will compare all three methods with the full likelihood approach. The main emphasis of
this paper is to illustrate that appropriate partitioning of data and models, in combination with
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pseudo-likelihood methodology, makes ﬁtting complex models to large data sets feasible, which
otherwise would not be feasible.
The paper is organized as follows. The motivating data are introduced in Section 2 and their
analysis discussed in Section 6. The theoretical concepts behind the proportional odds mixed model
(POMM) and short overview of the classical approach for joint modeling are given in Sections 3 and
4, respectively. In Section 5, the existing pseudo-likelihood methodology will be reviewed and the
new combined method introduced. Concluding remarks are given in Section 7.
2 Motivating case study
In Belgium, the diabetes project was conducted from January 2005 until December 2006, with the
aim to study the eﬀect of implementing a structured model for chronic diabetes care based on the
patients’ clinical outcomes. General practitioners (GP’s) were oﬀered assistance and could redirect
patients to the diabetes care team, consisting of a nurse educator, a dietician, an ophthalmologist,
and an internal medicine doctor. A total of 120 GP’s and 2495 patients took part in the study.
During the project, several outcomes useful to evaluate how well diabetes is controlled were
measured, at the moment the program was initiated (time T0) and one year later (T1). The most
important outcomes were LDL-cholesterol (low-density lipoprotein cholesterol, mg/dl), HbA1c
(glycosylated hemoglobin, %) and SBP (systolic blood pressure, mmHg). Furthermore, experts
speciﬁed cut-oﬀ values to divide every outcome into more than two target groups (multiple
targets). These clinical targets are of major scientiﬁc interest. For example, the values of HbA1C
were divided into three groups: (1) <7%, (2) >7% and <8%, and (3) 8%. Hence, when the patient
moves to a lower HBA1C group, as a result of the treatment, then this can be regarded as an
improvement of his/her physical condition. The target groups for LDL-cholesterol and SBP were
deﬁned in a similar way. If one is interested in verifying whether a new care program
simultaneousely improves the targets of HbA1C, LDL-cholestrol and SBP, then the multiple
targets of each response can no longer be regarded as separate outcomes, but as part of a joint
trial endpoint. The data are discussed in detail in Borgermans et al.19
In this paper, we will study modeling of the joint trial endpoint, in order to be able to study the
association between separate components, and how it evolves over time, as well as to explore some
demographical and disease-related characterictics of the patient. More details about the modeling
will be discussed in the methodology section. Because of missing values in one or more of the
covariates in the model, the data were reduced to 2259 patients.
Time-point-speciﬁc descriptions of multiple targets for LDL-cholesterol, HbA1C, and SBP are
listed in Table 1. Table 2 shows the number of patients having 0, 1, 2, or 3 components of the joint
trial endpoint for the two time-points. From this we observe that 1659 patients have measurements
for all three components for both time-points. Among the incompleters, three patients had only SBP
measurements and no measurements of LDL-Cholesterol and Hb1Ac.
3 Generalized linear mixed models
The principle of linear mixed models, introduced by Laird and Ware,1 was reformulated to non-
continuous data (generelized linear mixed models, GLMM) by Breslow and Clayton,2 Wolﬁnger
and O’Connell,3 and Engel and Keen.4 A nice overview of the existing GLMM with a lot of
applications can be found in the book of Molenberghs and Verbeke.13
Assume that a longitudinal non-normal outcome can be appropriately modelled using a mixed
model. For this outcome, let Yij denote the jth measurement for subject i ¼ 1, . . . ,N, j ¼ 1, . . . , ni.
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The ni measurements are grouped into a vector Yi. The GLMM assumes that conditionally on the
random eﬀects bi, with zero mean and covariance matrix D, the elements Yij of Yi are independent,
with densities belonging to the exponential family, i.e. of the form
fið yijjbi, n,Þ ¼ exp 1½ yijij   ðijÞ þ cð yij,Þ
 
,
with
½ 0ðijÞ ¼ ðijÞ ¼ ½EðYijjbi, nÞ ¼ x0ijnþ z0ijbi,
in which xij and zij are k-dimensional and q-dimensional vectors with known covariate values, n a
k-dimensional vector of unknown ﬁxed regression coeﬃcients, and  a scale parameter.
Table 1. Diabetes data: number of observations with corresponding targets of the outcomes at two time-points.
# Observations
LDL-chol. Targets T0 T1
1: <100mg/dl 819 1106
2: 100mg/dl and< 115mg/dl 381 312
3: 115mg/dl and< 130mg/dl 287 220
4: 130mg/dl 485 250
Missing 287 371
HbA1C Targets T0 T1
1: <7% 1201 1357
2: 7% and <8% 604 474
3: 8% 413 176
Missing 41 252
SBP targets T0 T1
1: 130 mmHg 1103 1152
2: >130mmHg and 140mmHg 551 469
3: >140mmHg and 160mmHg 466 324
4: >160 mmHg 136 75
Missing 3 239
Table 2. Diabetes data: number of patients with number of available components for two time-points.
T1
0 1 2 3 Total
0 0 0 1 2 3
T0 1 2 2 5 12 21
2 45 2 39 195 280
3 179 16 101 1659 1955
Total 226 19 146 1868 2259
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In general, inference is based on the marginal model for Yi, which is obtained by integrating out
the random eﬀects
fiðyiÞ ¼
Z
fiðyijbiÞ f ðbiÞdbi: ð1Þ
In contrast to linear mixed models, the integral in (1) cannot be calculated analytically for most
generalized linear mixed models, while existing analytical expressions tend to be cumbersome.20,21
Hence, numerical approximations are needed (see Molenberghs and Verbeke13).
A special case of GLMM, of particular interest to this work, is the proportional odds mixed
model (POMM) for ordinal outcomes. Let Yij be ordinal with values r ¼ 1, . . . ,R. We ﬁrst deﬁne R
indicator variables as
Wr,ij ¼
1 if Yij ¼ r,
0 otherwise:

Evidently, the R dummies are jointly redundant but any R 1 subset is not. Group the dummies into
vectors Wij for a speciﬁc subject i and occasion j, and further into Wi for all dummies across all
occasions for subject i. We assume a multinomial distribution Wij  multinomial ðijÞ, with
ij ¼ ð1,ij, . . . ,r,ij, . . . ,R,ijÞ. The multinomial distribution at a given occasion is determined by
the modeling choice made for the ordinal outcome. The probabilities can be written as
r,ij ¼
1,ij if r ¼ 1,
r,ij  r1,ij if 15 r5R,
1 R1,ij if r ¼ R
8><>:
where, assuming proportional odds
r,ij ¼
exp 0r þ x0ijnþ z0ijbi
 
1þ exp 0r þ x0ijnþ z0ijbi
  :
Here, 01  . . .  0ðR1Þ are intercepts, n ﬁxed regression coeﬃcients, bi a vector of normally
distributed random eﬀects, and xij (zij) the design vector for the ﬁxed (random) eﬀects at occasion j.
4 Joint models for multiple outcomes: classical approach
Consider L longitudinal outcomes, all of ordinal type. For each outcome, a POMM, as described in
Section 3, can be speciﬁed. All L outcomes can be modelled jointly by deﬁning a joint distribution of
random eﬀects. Now, bi represents the vector with all random eﬀects of all POMMs. Further, we will
call this model multivariate joint POMM.
Assuming subjects to be independent, then it immediately follows from the independence of
Y1,i, Y2,i; . . . ;YL,i conditional on bi, that the log-likelihood contribution for subject i to the full
joint mixed model is given by
liðhjy1i, y2i, . . . , yLiÞ ¼ log
Z YL
l¼1
fliðylijbiÞ f ðbiÞdbi
 !
, ð2Þ
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with h the vector of all parameters (ﬁxed eﬀects as well as covariance parameters). Except for
special cases (e.g. with linear models), the integral in (2) cannot be calculated analytically and
numerical approaches are needed. In this paper, we will use numerical integration, more
speciﬁcally adaptive Gaussian quadrature, which has been implemented in the SAS procedure
NLMIXED.13,22,23 The potentially high dimension of the random eﬀects in bi rapidly leads to an
increase in computation time because of the joint maximization of a large number of terms that need
to be numerically evaluated.
5 Pseudo-likelihood methodology
5.1 Introduction
As mentioned in Section 4, in general, ﬁtting joint GLMMs by maximizing likelihood becomes
cumbersome and for large numbers of outcomes even infeasible. Instead, an alternative approach
based on pseudo-likelihood methodology can be used, the principal idea of which is to replace the
joint likelihood function by a function that is easier to maximize. This methodology makes use of
estimating functions,24 like many other methods (generalized estimating equations, partial
likelihood, etc.). An important diﬀerence with, for example, partial likelihood is that pseudo-
likelihood retains a fully parametric speciﬁcation. Taking into account suitable regularity
conditions, it can be shown that pseudo-likelihood maximization yields a consistent,
asymptotically normally distributed estimator for the parameter vector.25,26 In the book of
Molenberghs and Verbeke13 (chaps 9, 12, 21, 22, 24 and 25), the formal deﬁnition of pseudo-
likelihood is given, its asymptotic properties and pseudo-likelihood inference considered, and a
broad range of applications discussed in the case of marginal, conditional and subject-speciﬁc
models, as well as joint modeling.
In the present paper, we will apply three diﬀerent ﬁtting techniques based on pseudo-likelihood:
pairwise modeling, independent partitions modeling and, ﬁnally, the combined case: pairwise
modeling of independent partitions. For each modeling case, a pseudo-likelihood function will be
formulated and the method for estimating the parameters and the covariance matrix discussed.
5.2 Pairwise modeling
Applying the methodology of Fieuws and Verbeke,14 we ﬁt a bivariate joint POMM to each possible
pair of longitudinal outcomes. Hence, for L longitudinal sequences LðL 1Þ=2 bivariate models will
be ﬁtted. Of course, in the pairwise approach, most of the parameters (but not all of them) will be
estimated L 1 times: for example, consider the ﬁxed eﬀects in the model for the ﬁrst longitudinal
outcome, because the ﬁrst outcome will be paired with the second, then with the third, and so on, up
to the Lth outcome. In order to obtain a single estimate for the parameters in h, an average overall
diﬀerent bivariate POMMs is taken.
The ﬁrst formal step of this procedure is to maximize the log-likelihood of each bivariate model
separately
lrsðhr,sjyr, ysÞ ¼
XN
i¼1
lrsiðhr,sjyri, ysiÞ,
where r ¼ 1, . . . ,L 1, and s ¼ rþ 1, . . .L, and N the number of subjects. As result, we obtain an
estimate for hr,s, the vector of all parameters in a speciﬁc pair (r, s).
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Let h be the vector contaning the parameters of all LðL 1Þ=2 bivariate models. The pseudo-
likelihood then takes the following form
pl ðhÞ ¼ l12ðh1,2jy1, y2Þ þ l13ðh1,3jy1, y3Þ þ    þ lðL1ÞLðhL1,LjyL1, yLÞ:
Then, within the pseudo-likelihood framework, as was shown for the vector-valued parameter case
by Arnold and Strauss25 and by Geys et al.,26 an asymptotic multivariate distribution for h^ can be
derived as follows ﬃﬃﬃﬃ
N
p
ðh^ hÞ  Nð0, J1KJ1Þ
where J1KJ1 is a ‘sandwich-type’ robust variance estimator (see Appendix 1). Let h^ be our vector
of interest, the vector of the average over all available estimates. Then, to pass from the distribution
of h^ to h^, Fieuws and Verbeke14 used an appropriate linear combination matrix A. Then, h^ ¼ A0h^
and the pseudo-likelihood inferences for the elements of h^ will be based on the following
assymptotic distribution ﬃﬃﬃﬃ
N
p
ðh^  hÞ ¼
ﬃﬃﬃﬃ
N
p
ðA0h^ A0hÞ  Nð0,A0J1KJ1AÞ: ð3Þ
5.3 Partitioned samples
The idea of Fieuws and Verbeke,14 reviewed in Section 5.2, was adopted by Molenberghs et al.17 and
applied to the case where partitioning of large data is appropriate for model ﬁtting.
Consider a large sample, broken into m ¼ 1, . . . ,M independent subsamples, each of size n. Then,
N ¼ M  n. (The extension to diﬀerent subsample sizes is straightforward, then N ¼PMm¼1 nm). In
this case, the ﬁst step is to maximize the log-likelihood for each subsample separately
lmðhmjym,1, . . . , ym,LÞ ¼
Xn
i¼1
lmiðhmjym,1, . . . , ym,LÞ:
The estimation of the parameters will be done by maximizing the following pseudo-likelihood
function
pl ðhÞ ¼ l1ðh1jy1,1, . . . , y1,LÞ þ l2ðh2jy2,1, . . . , y2,LÞ þ    þ lMðhMjyM,1, . . . , yM,LÞ_
Note that all hm are equal to h
 and the parameter vector h from Section 5.2 takes the form
ðh, h, . . . , hÞ. Then, the average estimator over all subsamples can be deﬁned as follows
h^ ¼ 1
M
XM
m¼1
h^m: ð4Þ
Due to the fact that modeling was performed on independent subsamples, the mutual information
between the subsamples will be zero. Hence, blocks Jm and Km are identical up to the sign: Jm¼Km
(see Appendix 2). Using these results, the approximated distribution in (3) can be simpliﬁed toﬃﬃﬃﬃ
N
p
ðh^  hÞ ¼
ﬃﬃﬃﬃ
N
p
ðA0h^ A0hÞ  Nð0, M  A0J1AÞ ð5Þ
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where
A ¼ 1
M
ðI, I, . . . , IÞ ð6Þ
with I the identity matrix with linear dimensions equal to the length of vector h. An alternative way
to estimate the covariance matrix of h^ is by using the observed information matrices that contain
the second derivatives of the pseudo-likelihoodX
ðh^Þ ¼ 1
N
 1
M
XM
m¼1
cJm1 !: ð7Þ
It is important to note that this method is fully eﬃcient in the sense that the Crame´r-Rao lower
bound is reached. This is due to the fact that, for every partition, a genuine likelihood was used for
model ﬁtting. This is true even though the obtained vector of estimates may diﬀer from the one
obtained when analyzing the outcomes in full.
Molenberghs et al.17 also investigated the case of model ﬁtting given dependent subsamples.
Then, the asymptotic distribution of the vector h^ will be derived using the general case, as in
equation (3), with A as in equation (6). The reason behind it is that the oﬀ-diagonal blocks of K,
the information matrix with the products of the ﬁrst derivatives, are generally non-zero.
5.4 Pairwise modeling of independent subsamples
In this paper, we will introduce a combined method: pairwise modeling of independent subsamples.
Therefore, formally, we have to take the following steps: (1) divide the data into M independent
subsamples, each of size n (or, in general, nm), (2) apply pairwise ﬁtting on each
subsample separately, and (3) combine the results from the two previous steps in a single
inference for vector h^. Clearly, model ﬁtting is in this case is based on the pseudo-likelihood
function of the form
pl ðhÞ ¼
XM
m¼1
X
r,s
lm,rs,
where
lm,rsðhm,rsjym,r, ym,sÞ ¼
Xn
i¼1
lm,rsiðhm,rsjym,ri, ym,siÞ,
and r ¼ 1, . . . ,L 1, and s ¼ rþ 1, . . .L, ym,ri and ym,si are subvectors of outcomes r and s for
subject i, the subject that is included in subsample m. Note that the independent subsamples
contain diﬀerent subjects.
For each of m independent subsamples (because of pairwise modeling), most parameters will be
estimated L 1 times. Hence, in this case, matrix A will contain the weights over all partitions and
all pairs. The asymptotic distribution of the vector of estimators h^ ¼ A0h^, averaged over all pairs
and partitions, will be a generalization of (3) and (5)ﬃﬃﬃﬃ
N
p
ðh^  hÞ ¼
ﬃﬃﬃﬃ
N
p
ðA0h^ A0hÞ  Nð0,M  A0J1KJ1AÞ
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with J a block diagonal matrix with diagonal blocks equal to
Jm,pp ¼  1
n
Xn
i¼1
E
@2lm,pi
@hm,p@h
0
m,p
 !
where m ¼ 1, . . . ,M, p ¼ 1, . . . ,LðL 1Þ=2. K is also a block-diagonal matrix but with larger blocks
Km,	. Each Km,	 block corresponds to the pairwise modeling within a partition. It implies that Km,	 is
a symmetric matrix containing blocks
Km,pq ¼ 1
n
Xn
i¼1
E
@lm,pi
@hm,p
@lm,qi
@h0m,q
 !
with p, q ¼ 1, . . . ,LðL 1Þ=2.
Table 3. Diabetes study.
Outcome Effect Par. ML PLp
LDL-chol. Int. 1 1,01 1.076 (0.108) 1.073 (0.107)
Targets Int. 2 1,02 0.155 (0.105) 1.157 (0.106)
Int. 3 1,03 1.257 (0.110) 1.258 (0.115)
Time 1,1 1.025 (0.076) 1.025 (0.071)
Diab. dur. T0=10 1,2 0.213 (0.088) 0.216 (0.090)
Gender 1,3 0.497 (0.110) 0.497 (0.110)
Insulin 1,4 0.853 (0.150) 0.829 (0.153)
RI sd.
ﬃﬃﬃﬃﬃﬃ
d11
p
1.852 (0.089) 1.849 (0.085)
HbA1c Int. 1 2,01 0.901 (0.110) 0.902 (0.110)
Targets Int. 2 2,02 3.195 (0.139) 3.194 (0.141)
Time 2,1 1.068 (0.081) 1.068 (0.077)
Diab.dur. T0=10 2,2 0.532 (0.088) 0.531 (0.090)
Gender 2,3 0.183 (0.114) 0.181 (0.115)
Insulin 2,4 1.103 (0.140) 1.108 (0.145)
RI sd.
ﬃﬃﬃﬃﬃﬃ
d22
p
1.923 (0.095) 1.920 (0.089)
SBP Int. 1 3,01 0.151 (0.092) 0.150 (0.093)
Targets Int. 2 3,02 1.416 (0.099) 1.417 (0.100)
Int. 3 3,03 3.740 (0.134) 3.741 (0.137)
Time 3,1 0.508 (0.067) 0.509 (0.066)
Diab. dur. T0=10 3,2 0.098 (0.076) 0.096 (0.076)
Gender 3,3 0.185 (0.096) 0.185 (0.097)
Insulin 3,4 0.193 (0.127) 0.178 (0.129)
RI sd.
ﬃﬃﬃﬃﬃﬃ
d33
p
1.620 (0.076) 1.619 (0.076)
LDL-chol. targets and
HbA1c targets Cov. RI’s d12 0.472 (0.151) 0.459 (0.158)
LDL-chol. targets and
SBP targets Cov. RI’s d13 0.525 (0.125) 0.513 (0.126)
HbA1c targets and
SBP targets Cov. RI’s d23 0.505 (0.131) 0.493 (0.136)
Note: Estimates (standard errors) of the regression coefficients for estimation methods for the Q¼ 3 case. ML: maximization of full
likelihood; PLp: pairwise modeling.
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For pairwise modeling of independent subsamples, the pieces consisted of pairs constructed
within every subsample. They are analyzed separately and the ﬁtting results combined into a
single point and precision estimator using the appropriate pseudo-likelihood rules. We illustrate
this with an example. Assume the data were divided into M¼ 2 independent subsamples, and then
for each partition, we obtain h^m and its covariance by using equation (3) with N replaced by n.
Denote the results of the ﬁrst step by h^1, h^

2 with the corresponding covariance matricesPðh^1Þ, Pðh^2Þ. Then, by applying equation (4), the overall estimator of the parameters equals
h^ ¼ 1
2
ðh^1 þ h^2Þ:
Table 4. Diabetes study.
Outcome Effect Par. PLs PLps
LDL-chol. Int. 1 1,01 1.063 (0.109) 1.061 (0.110)
Targets Int. 2 1,02 0.183 (0.107) 0.185 (0.109)
Int. 3 1,03 1.291 (0.112) 1.292 (0.118)
Time 1,1 1.025 (0.077) 1.025 (0.072)
Diab. dur. T0=10 1,2 0.198 (0.090) 0.201 (0.091)
Gender 1,3 0.497 (0.111) 0.497 (0.112)
Insulin 1,4 0.877 (0.153) 0.852 (0.156)
RI sd.
ﬃﬃﬃﬃﬃﬃ
d11
p
1.853 (0.090) 1.849 (0.087)
HbA1c Int. 1 2,01 0.883 (0.111) 0.883 (0.111)
Targets Int. 2 2,02 3.189 (0.140) 3.187 (0.141)
Time 2,1 1.083 (0.082) 1.084 (0.078)
Diab. dur. T0=10 2,2 0.513 (0.090) 0.511 (0.091)
Gender 2,3 0.152 (0.114) 0.150 (0.116)
Insulin 2,4 1.151 (0.141) 1.157 (0.144)
RI sd.
ﬃﬃﬃﬃﬃﬃ
d22
p
1.912 (0.096) 1.910 (0.091)
SBP Int. 1 3,01 0.139 (0.093) 0.139 (0.094)
Targets Int. 2 3,02 1.432 (0.100) 1.432 (0.101)
Int. 3 3,03 3.776 (0.136) 3.777 (1.139)
Time 3,1 0.508 (0.067) 0.509 (0.066)
Diab. dur. T0=10 3,2 0.115 (0.078) 0.113 (0.078)
Gender 3,3 0.184 (0.097) 0.185 (0.097)
Insulin 3,4 0.206 (0.128) 0.192 (0.130)
RI sd.
ﬃﬃﬃﬃﬃﬃ
d33
p
1.620 (0.077) 1.619 (0.077)
LDL-chol. targets and
HbA1c targets Cov. RI’s d12 0.491 (0.155) 0.478 (0.164)
LDL-chol. targets and
SBP targets Cov. RI’s d13 0.527 (0.127) 0.516 (0.130)
HbA1c targets and
SBP targets Cov. RI’s d23 0.511 (0.133) 0.498 (0.138)
Note: Estimates (standard errors) of the regression coefficients for estimation methods for the Q ¼ 3 case. PLs: partitioned samples
(M ¼ 5); PLps: combined modeling (M ¼ 5).
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Table 5. Diabetes study.
ML PLp PLs PLps
LDL-chol. Targets 1.000 1.000 1.000 1.000
HbA1C Targets 0.133 1.000 0.129 1.000 0.139 1.000 0.136 1.000
SBP Targets 0.175 0.162 1.000 0.171 0.159 1.00 0.176 0.165 1.000 0.172 0.161 1.00
Note: Estimated correlation matrix for the random intercepts for the Q ¼ 3 case. ML: maximization of full likelihood; PLp: pairwise
modeling; PLs: partitioned samples (M ¼ 5); PLps: combined modeling (M ¼ 5).
Table 6. Diabetes study.
Outcome 1 Outcome 2 Outcome 3 Partition Pair CPU Time
ML: maximization of full likelihood
LDL-Chol.targets HbA1c Targets SBP targets 0:07:13
PLp : pairwise modeling, three parallel processes
LDL-Chol. targets HbA1C targets 1 0:01:12
LDL-Chol. targets SBP targets 2 0:01:23
HbA1c targets SBP targets 3 0:01:12
PLs : partitioned samples (M¼ 5), five parallel processes
LDL-Chol. targets HbA1c targets SBP targets 1 0:01:12
LDL-Chol. targets HbA1c targets SBP targets 2 0:01:21
LDL-Chol. targets HbA1c targets SBP targets 3 0:01:14
LDL-Chol. targets HbA1c targets SBP targets 4 0:01:18
LDL-Chol. targets HbA1c targets SBP targets 5 0:01:17
PLps: combined modeling (M¼ 5), 15 parallel processes
LDL-Chol. targets HbA1C targets 1 1 0:00:14
LDL-Chol. targets SBP targets 1 2 0:00:17
HbA1c targets SBP targets 1 3 0:00:15
LDL-Chol. targets HbA1C targets 2 1 0:00:15
LDL-Chol. targets SBP targets 2 2 0:00:20
HbA1c targets SBP targets 2 3 0:00:17
LDL-Chol. targets HbA1C targets 3 1 0:00:14
LDL-Chol. targets SBP targets 3 2 0:00:17
HbA1c targets SBP targets 3 3 0:00:16
LDL-Chol. targets HbA1C targets 4 1 0:00:15
LDL-Chol. targets SBP targets 4 2 0:00:18
HbA1c targets SBP targets 4 3 0:00:16
LDL-Chol. targets HbA1C targets 5 1 0:00:16
LDL-Chol. targets SBP targets 5 2 0:00:19
HbA1c targets SBP targets 5 3 0:00:17
Note: Computation time (hours:minutes:seconds) for different estimation methods for the Q ¼ 3 case. ML: maximization of full
likelihood; PLp: pairwise modeling; PLs: partitioned samples (M ¼ 5); PLps: combined modeling (M ¼ 5).
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Finally, the assymptotic covariance of h^ can be constructed similar to equation (7)X
ðh^Þ ¼ 1
N
1
2
X
ðh^1Þ þ
X
ðh^2Þ
n o 	
:
6 Analysis of diabetes study
As an illustration, we analyze the diabetes data introduced in Section 2. In this analysis, the experts
deﬁned multiple targets for HbA1C, LDL-cholestrol and SBD which are regarded as a joint trial
endpoint. Denote the components of this joint endpoint as Y1ij, Y2ij, and Y3ij with the subscripts i
Table 7. Diabetes study.
Outcome Effect Par. ML vs. PLp ML vs. PLs ML vs. PLps
LDL-chol. Int. 1 1,01 1.008 0.974 0.969
Targets Int. 2 1,02 0.967 0.967 0.922
Int. 3 1,03 0.921 0.961 0.876
Time 1,1 1.143 0.991 1.131
Diab. dur. T0=10 1,2 0.968 0.954 0.932
Gender 1,3 0.987 0.976 0.958
Insulin 1,4 0.967 0.968 0.929
RI sd.
ﬃﬃﬃﬃﬃﬃ
d11
p
1.091 0.966 1.041
HbA1c Int. 1 2,01 1.001 0.990 0.991
Targets Int. 2 2,02 0.974 0.988 0.963
Time 2,1 1.122 0.978 1.088
Diab. dur. T0=10 2,2 0.958 0.950 0.943
Gender 2,3 0.976 0.988 0.968
Insulin 2,4 0.936 0.980 0.950
RI sd.
ﬃﬃﬃﬃﬃﬃ
d22
p
1.128 0.984 1.100
SBP Int. 1 3,01 0.984 0.982 0.960
Targets Int. 2 3,02 0.974 0.980 0.947
Int. 3 3,03 0.953 0.971 0.923
Time 3,1 1.032 0.995 1.027
Diab. dur. T0=10 3,2 1.014 0.953 0.946
Gender 3,3 0.993 0.984 0.977
Insulin 3,4 0.963 0.981 0.945
RI sd.
ﬃﬃﬃﬃﬃﬃ
d33
p
0.991 0.975 0.965
LDL-chol. targets and
HbA1c targets Cov. RI’s d12 0.912 0.951 0.852
LDL-chol. targets and
SBP targets Cov. RI’s d13 0.985 0.962 0.928
HbA1c targets and
SBP targets Cov. RI’s d23 0.926 0.977 0.910
Note: ARE for maximum likelihood and pseudo-likelihood methods for the Q ¼ 3 case. ML vs. PLp¼ variance ML vs. variance PLp;
ML vs. PLs¼ variance ML vs. variance PLs (M ¼ 5); ML vs. PLps ¼ variance ML vs. variance PLps (M ¼ 5).
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and j indicating a measurement for subject i (i ¼ 1, . . . , 2259) at occasion j (j¼ 1, 2). Since every
component was deﬁned on an ordinal scale, we can specify for every one of them a univariate
POMM. For simplicity and without loss of generality, we will use the same covariate structure.
More speciﬁcally, for the lth outcome (l¼ 1, 2, 3) with R categories on an ordinal scale, we assume
the following model
logit ½PðYlij  rÞ ¼ l,0r þ l,1tij þ l,2X1,i þ l,3X2,i þ l,4X3,ij,
where r ¼ 1, . . . , ðR 1Þ, tij is the time point at which the outcome is measured, i.e. tij¼ 0 or 1. For
the corresponding conditional models, in order to capture the association between the measurements
within the same subject for a certain response, three random intercepts will be included: b1i, b2i,
and b3i.
Table 8. Diabetes study.
Outcome Effect Par. ML PLp
LDL-chol. Int. 1 1,01 1.092 (0.112) 1.089 (0.111)
Targets Int. 2 1,02 0.167 (0.109) 0.169 (0.110)
Int. 3 1,03 1.293 (0.114) 1.295 (0.119)
Time 1,1 1.044 (0.077) 1.044 (0.073)
Diab.dur. T0=10 1,2 0.220 (0.091) 0.224 (0.093)
Gender 1,3 0.513 (0.114) 0.513 (0.114)
Insulin 1,4 0.879 (0.155) 0.854 (0.158)
RI sd.
ﬃﬃﬃﬃﬃﬃ
d11
p
1.956 (0.097) 1.954 (0.099)
HbA1c Int. 1 2,01 0.964 (0.117) 0.965 (0.118)
Targets Int. 2 2,02 3.331 (0.149) 3.331 (0.155)
Time 2,1 1.095 (0.083) 1.095 (0.079)
Diab.dur. T0=10 2,2 0.565 (0.093) 0.564 (0.095)
Gender 2,3 0.190 (0.120) 0.188 (0.120)
Insulin 2,4 1.114 (0.146) 1.120 (0.151)
RI sd.
ﬃﬃﬃﬃﬃﬃ
d22
p
2.077 (0.105) 2.076 (0.107)
SBP Int. 1 3,01 0.143 (0.094) 0.142 (0.095)
Targets Int. 2 3,02 1.445 (0.101) 1.446 (0.103)
Int. 3 3,03 3.800 (0.137) 3.797 (0.143)
Time 3,1 0.514 (0.067) 0.515 (0.067)
Diab. dur. T0=10 3,2 0.102 (0.078) 0.099 (0.077)
Gender 3,3 0.188 (0.099) 0.189 (0.098)
Insulin 3,4 0.201 (0.129) 0.186 (0.132)
RI sd.
ﬃﬃﬃﬃﬃﬃ
d33
p
1.680 (0.080) 1.680 (0.084)
LDL-chol. targets and
HbA1c targets Cov. RI’s d12 0.508 (0.164) 0.491 (0.168)
LDL-chol. targets and
SBP targets Cov. RI’s d13 0.552 (0.133) 0.539 (0.133)
HbA1c targets and
SBP targets Cov. RI’s d23 0.536 (0.142) 0.522 (0.145)
Note: Estimates (standard errors) of the regression coefficients for estimation methods for the Q ¼ 15 case. ML: maximization of
full likelihood; PLp: pairwise modeling.
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Table 9. Diabetes study.
Outcome Effect Par. PLs PLps
LDL-chol. Int. 1 1,01 1.077 (0.113) 1.075 (0.113)
Targets Int. 2 1,02 0.201 (0.111) 0.202 (0.113)
Int. 3 1,03 1.335 (0.117) 1.336 (0.123)
Time 1,1 1.045 (0.077) 1.044 (0.074)
Diab. dur. T0=10 1,2 0.206 (0.094) 0.209 (0.095)
Gender 1,3 0.513 (0.116) 0.513 (0.116)
Insulin 1,4 0.902 (0.158) 0.876 (0.161)
RI sd.
ﬃﬃﬃﬃﬃﬃ
d11
p
1.965 (0.098) 1.960 (0.102)
HbA1c Int. 1 2,01 0.943 (0.117) 0.944 (0.118)
Targets Int. 2 2,02 3.323 (0.149) 3.323 (0.156)
Time 2,1 1.111 (0.084) 1.112 (0.081)
Diab. dur. T0=10 2,2 0.544 (0.096) 0.543 (0.096)
Gender 2,3 0.156 (0.121) 0.155 (0.121)
Insulin 2,4 1.166 (0.148) 1.172 (0.150)
RI sd.
ﬃﬃﬃﬃﬃﬃ
d22
p
2.066 (0.106) 2.066 (0.108)
SBP Int. 1 3,01 0.131 (0.095) 0.131 (0.096)
Targets Int. 2 3,02 1.462 (0.102) 1.463 (0.105)
Int. 3 3,03 3.834 (0.140) 3.836 (0.146)
Time 3,1 0.513 (0.068) 0.515 (0.067)
Diab. dur. T0=10 3,2 0.120 (0.080) 0.118 (0.080)
Gender 3,3 0.187 (0.099) 0.189 (0.099)
Insulin 3,4 0.217 (0.131) 0.203 (0.133)
RI sd.
ﬃﬃﬃﬃﬃﬃ
d33
p
1.682 (0.081) 1.682 (0.085)
LDL-chol. targets and
HbA1c targets Cov. RI’s d12 0.524 (0.169) 0.508 (0.175)
LDL-chol. targets and
SBP targets Cov. RI’s d13 0.553 (0.136) 0.541 (0.137)
HbA1c targets and
SBP targets Cov. RI’s d23 0.544 (0.144) 0.530 (0.147)
Note: Estimates (standard errors) of the regression coefficients for estimation methods for the Q ¼ 15 case. PLs: partitioned
samples (M ¼ 5); PLps: combined modeling (M ¼ 5).
Table 10. Diabetes study.
ML PLp PLs PLps
LDL-chol. targets 1.000 1.000 1.000 1.000
HbA1C targets 0.125 1.000 0.121 1.000 0.129 1.000 0.126 1.000
SBP targets 0.168 0.154 1.000 0.164 0.150 1.00 0.167 0.156 1.000 0.164 0.153 1.00
Note: Estimated correlation matrix for the random intercepts for the Q¼ 15 case. ML: maximization of full likelihood; PLp: pairwise
modeling; PLs: partitioned samples (M¼ 5); PLps: combined modeling (M¼ 5).
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In order to capture the correlation between three responses, an assumption about the distribution
of the vector of random eﬀects bi ¼ ðb1i, b2i, b3iÞ0 should be made. For example, to apply the model,
the following assumption can be speciﬁed
bi  Nð0,DÞ ð8Þ
where D is a covariance matrix of random eﬀects with elements duv (u,v¼ 1,2,3).
Four analyses are performed: (1) the classical ﬁtting of joint models by maximizing the full joint
likelihood (ML) and then the three alternative pseudo-likelihood methods, (2) pairwise modeling
(PLp), (3) modeling using partitioned independent subsamples (PLs), and (4) pairwise modeling of
independent subsamples (PLps).
Parameter estimates of this model can be obtained by maximizing the full likelihood, based on
subject speciﬁc contributions from equation (2), after integrating out the random eﬀects by using
Table 11. Diabetes study.
Outcome 1 Outcome 2 Outcome 3 Partition Pair CPU Time
ML: maximization of full likelihood
LDL-Chol.Targets HbA1c Targets SBP targets 10:02:42
PLp: pairwise modeling, three parallel processes
LDL-Chol. targets HbA1C Targets 1 0:16:01
LDL-Chol. targets SBP Targets 2 0:20:04
HbA1c targets SBP Targets 3 0:16:52
PLs: partitioned samples, M¼ 5, five parallel processes
LDL-Chol. targets HbA1c targets SBP targets 1 2:08:40
LDL-Chol. targets HbA1c targets SBP targets 2 2:31:20
LDL-Chol. targets HbA1c targets SBP targets 3 2:14:29
LDL-Chol. targets HbA1c targets SBP targets 4 2:23:29
LDL-Chol. targets HbA1c targets SBP targets 5 2:24:58
PLps: combined modeling, M¼ 5, 15 parallel processes
LDL-Chol. targets HbA1C targets 1 1 0:03:09
LDL-Chol. targets SBP targets 1 2 0:04:12
HbA1c targets SBP targets 1 3 0:03:25
LDL-Chol. targets HbA1C targets 2 1 0:03:30
LDL-Chol. targets SBP targets 2 2 0:04:11
HbA1c targets SBP targets 2 3 0:03:40
LDL-Chol. targets HbA1C targets 3 1 0:02:58
LDL-Chol. targets SBP targets 3 2 0:04:11
HbA1c targets SBP targets 3 3 0:03:34
LDL-Chol. targets HbA1C targets 4 1 0:03:23
LDL-Chol. targets SBP targets 4 2 0:04:07
HbA1c targets SBP targets 4 3 0:03:58
LDL-Chol. targets HbA1C targets 5 1 0:03:30
LDL-Chol. targets SBP targets 5 2 0:04:17
HbA1c targets SBP targets 5 3 0:03:25
Note: Computation time (hours:minutes:seconds) for different estimation methods for the Q ¼ 15 case. ML: maximization of full
likelihood; PLp: pairwise modeling; PLs: partitioned samples (M ¼ 5); PLps: combined modeling (M ¼ 5).
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approximate methods (e.g. possibly adaptive, Gaussian quadrature). Because of the low number of
responses (here, only three), this method is computationally intensive but still feasible. It was
implemented with the SAS procedure NLMIXED, where for illustration’s sake, we took Q¼ 3
quadrature points in the approximation. The results for the estimates and the standard errors are
listed in Table 3 under ML. It should be noted that, as the full likelihood is maximized, the
asymptotic covariance of the parameter estimators are derived from the inverse of the Fisher’s
information matrix I1. It implies that the variance reaches the lower Crame´r-Rao bound and,
hence, the obtained estimator is a Crame´r-Rao eﬃcient estimator.
The three alternative methods are based on the maximization of the pseudo-likelihood function.
The theory behind these methods is decribed in Section 5. First, we will apply pairwise ﬁtting (PLp in
Table 3). For our case study, the information from three bivariate POMM models should be
combined. For PLs, our second pseudo-likelihood method, we split the data into M independent
Table 12. Diabetes study.
Outcome Effect Par. ML vs. PLp ML vs. PLs ML vs. PLps
LDL-chol. Int. 1 1,01 1.013 0.967 0.967
Targets Int. 2 1,02 0.972 0.959 0.917
Int. 3 1,03 0.916 0.953 0.861
Time 1,1 1.113 0.991 1.099
Diab. dur. T0=10 1,2 0.978 0.949 0.937
Gender 1,3 0.996 0.969 0.961
Insulin 1,4 0.969 0.961 0.924
RI sd.
ﬃﬃﬃﬃﬃﬃ
d11
p
0.948 0.962 0.900
HbA1c Int. 1 2,01 0.986 0.991 0.977
Targets Int. 2 2,02 0.920 0.988 0.909
Time 2,1 1.082 0.976 1.045
Diab. dur. T0=10 2,2 0.967 0.949 0.949
Gender 2,3 0.994 0.987 0.983
Insulin 2,4 0.936 0.979 0.950
RI sd.
ﬃﬃﬃﬃﬃﬃ
d22
p
0.975 0.985 0.950
SBP Int. 1 3,01 0.988 0.980 0.962
Targets Int. 2 3,02 0.963 0.978 0.935
Int. 3 3,03 0.923 0.969 0.891
Time 3,1 1.015 0.995 1.010
Diab. dur. T0=10 3,2 1.020 0.951 0.948
Gender 3,3 1.002 0.981 0.982
Insulin 3,4 0.967 0.979 0.945
RI sd.
ﬃﬃﬃﬃﬃﬃ
d33
p
0.909 0.972 0.880
LDL-chol. Targets and
HbA1c targets Cov. RI’s d12 0.957 0.940 0.882
LDL-chol. targets and
SBP targets Cov. RI’s d13 1.006 0.951 0.939
HbA1c targets and
SBP targets Cov. RI’s d23 0.952 0.974 0.933
Note: ARE for maximum likelihood and pseudo-likelihood methods for the Q ¼ 15 case. ML vs. PLp ¼ variance ML vs. variance PLp;
ML vs. PLs ¼ variance ML vs. Variance PLs (M ¼ 5); ML vs. PLps ¼ variance ML vs. variance PLps (M ¼ 5).
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subsamples, with M¼ 5 (see PLs in Table 4). Finally, we have our new, combined method of
pairwise modeling of independent subsamples (PLps in Table 4). As before, M¼ 5 partitions were
used. For PLs and PLps, we have chosen to divide the data using a completely randomized design at
subject level. While this is not strictly necessary, it can be sensible in many applications.
Note that there are four patients in the data with only SBP values and no values for LDL-
Cholesterol and HbA1C. For these patients, for PLp and PLps methods, the subjects-speciﬁc
information for the LDL-cholestrol and HbA1C target pair will be set equal to zero in K and J.
Also, to integrate out the random eﬀects in each submodel of the three pseudo-likelihood methods,
we will use Q¼ 3 as in the full model. All analyses have been performed with SAS procedures
NLMIXED and IML (version 9.3).
Several observations can be made. First, as the subsamples in PLs and PLps are not all of equal
size, the data were divided into roughly equal portions. For these two methods, the weights in matrix
A of all subsamples are made equal. This is not fully optimal, but as observed by Molenberghs
et al.,17 this approximation does not aﬀect the validity of the patitioned method and can only slightly
aﬀect the eﬃciency.
In general, the estimation methods of the parameters, based on the earlier deﬁned pseudo-
likelihood, should be assessed as valid ones. Except for a few cases (e.g. for some intercepts of
Table 13. Simulation study for two time-points with N Subjects ¼ 1000, N random samples ¼ 1000: MSE and
interval coverage for different estimation methods, for the Q ¼ 3 case.
ML PLp
Outcome Effect Par. 102MSE Int.Cov. 102MSE Int.Cov.
LDL-chol. Int. 1 1,01 ¼ 0:740 1.502 0.955 1.502 0.958
Targets Int. 2 1,02 ¼ 0:480 1.518 0.942 1.518 0.941
Int. 3 1,03 ¼ 1:580 1.848 0.930 1.851 0.928
Time 1,1 ¼ 1:050 0.966 0.961 0.966 0.961
Gender 1,2 ¼ 0:450 2.404 0.950 2.404 0.951
RI sd.
ﬃﬃﬃﬃﬃﬃ
d11
p ¼ 1:880 1.853 0.893 1.881 0.868
HbA1c Int. 1 2,01 ¼ 0:270 1.897 0.936 1.903 0.938
Targets Int. 2 2,02 ¼ 2:610 3.487 0.906 3.525 0.902
Time 2,1 ¼ 1:040 1.332 0.946 1.332 0.939
Gender 2,2 ¼ 0:090 3.001 0.945 2.997 0.946
RI sd.
ﬃﬃﬃﬃﬃﬃ
d22
p ¼ 2:150 3.407 0.830 3.484 0.787
SBP Int. 1 3,01 ¼ 0:190 1.175 0.963 1.171 0.963
Targets Int. 2 3,02 ¼ 1:380 1.317 0.957 1.317 0.955
Int. 3 3,03 ¼ 3:700 2.908 0.954 2.907 0.951
Time 3,1 ¼ 0:510 0.927 0.949 0.926 0.948
Gender 3,2 ¼ 0:190 1.934 0.959 1.923 0.962
RI sd.
ﬃﬃﬃﬃﬃﬃ
d33
p ¼ 1:620 1.219 0.941 1.257 0.920
LDL-chol. targets and
HbA1c targets Cov. RI’s d12 ¼ 0:808 4.876 0.931 4.819 0.940
LDL-chol. targets and
SBP targets Cov. RI’s d13 ¼ 1:218 3.585 0.920 3.606 0.920
HbA1c targets and
SBP targets Cov. RI’s d23 ¼ 1:393 4.546 0.932 4.558 0.937
ML: maximization of full likelihood; PLp: pairwise modeling.
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HbA1C targets and also some non-repeated measured covariates), where estimates for ML method
slightly diﬀer from those of PLs and PLps methods, all pseudo-likelihood methods yield
approximations that are very similar to those of the ML method. The standard errors of the PL
methods are also approximately equal to those of the ML method, with the largest diﬀerence for the
estimates of the covariances between the random intercepts, i.e. d12, d13, d23. Those of the PLps
method deviate the most, and in addition also the standard error of 1,03, a category-speciﬁc
intercept. To quantify these diﬀerences, we use the Asymptotic Relative Eﬃciency (ARE): the
ratio of the variance obtained with the maximum likelihood method and the one obtained with
one of the pseudo-likelihood methods. We summarize these ARE’s for all estimates in Appendix 3,
Table 7. From this table, we conclude that the majority of the parameters have an ARE larger than
95%, but for some cases it shrinks to 85–87% for the PLps method. In summary, when ﬁtting the
model with one of the alternative pseudo-likelihood methods, we have almost no loss in eﬃciency for
the main eﬀects except for some intercepts or some covariance parameters where a very small loss is
observed.
As an additional aim of our analysis, we estimate the strength of the association between three
outcomes. Table 5 presents the correlations obtained from the ﬁtted covariance matrix deﬁned in
equation (8). PLs and PLps methods estimate the correlations closer to the those of the full likelihood
Table 14. Simulation study for two time-points with N Subjects ¼ 1000, N random samples ¼ 1000: MSE and
interval coverage for different estimation methods, for the Q ¼ 3 case. PLs, M ¼ 5: partitioned samples, M ¼ 5; PLs, M
¼ 10: partitioned samples, M ¼ 10.
PLs, M¼ 5 PLs, M¼ 10
Outcome Effect Par. 102MSE Int.Cov. 102MSE Int.Cov.
LDL-chol. Int. 1 1,01 ¼ 0:740 1.555 0.953 1.633 0.878
Targets Int. 2 1,02 ¼ 0:480 1.545 0.942 1.585 0.874
Int. 3 1,03 ¼ 1:580 1.837 0.931 1.881 0.865
Time 1,1 ¼ 1:050 0.991 0.965 1.039 0.884
Gender 1,2 ¼ 0:450 2.468 0.952 2.542 0.879
RI sd.
ﬃﬃﬃﬃﬃﬃ
d11
p ¼ 1:880 1.801 0.899 1.777 0.839
HbA1c Int. 1 2,01 ¼ 0:270 1.952 0.941 2.023 0.868
Targets Int. 2 2,02 ¼ 2:610 3.275 0.925 3.244 0.872
Time 2,1 ¼ 1:040 1.368 0.947 1.443 0.872
Gender 2,2 ¼ 0:090 3.126 0.951 3.273 0.877
RI sd.
ﬃﬃﬃﬃﬃﬃ
d22
p ¼ 2:150 3.169 0.845 2.940 0.806
SBP Int. 1 3,01 ¼ 0:190 1.198 0.960 1.240 0.883
Targets Int. 2 3,02 ¼ 1:380 1.341 0.957 1.431 0.879
Int. 3 3,03 ¼ 3:700 3.180 0.959 4.229 0.869
Time 3,1 ¼ 0:510 0.944 0.943 0.984 0.869
Gender 3,2 ¼ 0:190 2.000 0.955 2.089 0.880
RI sd.
ﬃﬃﬃﬃﬃﬃ
d33
p ¼ 1:620 1.229 0.948 1.264 0.868
LDL-chol. targets and
HbA1c targets Cov. RI’s d12 ¼ 0:808 5.107 0.936 5.429 0.873
LDL-chol. targets and
SBP targets Cov. RI’s d13 ¼ 1:218 3.607 0.933 3.671 0.865
HbA1c targets and
SBP targets Cov. RI’s d23 ¼ 1:393 4.670 0.939 4.865 0.871
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method than PLp method. This is a quite logical result because for PLp the correlations were
estimated only once: one for each pair.
In practice, once the model is ﬁtted, it is used for hypothesis testing. Because of the close
connection between pseudo-likelihood and likelihood, inferences such as the Wald test, pseudo-
score test and pseudo-likelihood test have been developed (see Molenberghs and Verbeke13 chap.
9 and Geys et al.26). Suppose one is interested in testing whether there is a signiﬁcant joint evolution
over time for all outcomes. In this case, the asymptotic Wald test can be applied. For the
ML method, this test returns a value of 408.53 for the chi-square statistic. Using the
alternative distribution based on pseudo-likelihood, the same test can be performed also for
the PL methods: for PLp, PLs and PLps, the chi-square statistics are equal to 409.53, 407.86, and
406.60, respectively. Obviously, the values of the Wald statistic for the PL methods are very close
to that of the ML method and they all correspond to p< 0.0001. Hence, we reach the same
conclusion for the ML and the three PL methods: there is a signiﬁcant joint evolution for all
outcomes.
The most important advantage of replacing the full likelihood method by an alternative pseudo-
likelihood method is the gain in computation time. As all methods (ML, PLp, PLs, and PLps) were
applied using the same computer platform, a similar way of programming, and the same starting
Table 15. Simulation study for two time-points with N Subjects ¼ 1000, N random samples ¼ 1000: MSE and
interval coverage for different estimation methods, for the Q ¼ 3 case. PLps, M¼ 5: combined modeling, M ¼ 5; PLps,
M ¼ 10: combined modeling, M ¼ 10.
PLps, M¼ 5 PLps, M¼ 10
Outcome Effect Par. 102MSE Int.Cov. 102MSE Int.Cov.
LDL-chol. Int. 1 1,01 ¼ 0:740 1.554 0.955 1.639 0.953
Targets Int. 2 1,02 ¼ 0:480 1.544 0.946 1.594 0.947
Int. 3 1,03 ¼ 1:580 1.836 0.930 1.886 0.931
Time 1,1 ¼ 1:050 0.991 0.960 1.038 0.958
Gender 1,2 ¼ 0:450 2.467 0.953 2.552 0.954
RI sd.
ﬃﬃﬃﬃﬃﬃ
d11
p ¼ 1:880 1.827 0.879 1.793 0.887
HbA1c Int. 1 2,01 ¼ 0:270 1.957 0.943 2.025 0.948
Targets Int. 2 2,02 ¼ 2:610 3.304 0.915 3.260 0.937
Time 2,1 ¼ 1:040 1.368 0.936 1.435 0.935
Gender 2,2 ¼ 0:090 3.117 0.952 3.261 0.953
RI sd.
ﬃﬃﬃﬃﬃﬃ
d22
p ¼ 2:150 3.261 0.810 3.045 0.847
SBP Int. 1 3,01 ¼ 0:190 1.193 0.959 1.235 0.959
Targets Int. 2 3,02 ¼ 1:380 1.332 0.955 1.408 0.951
Int. 3 3,03 ¼ 3:700 3.127 0.954 4.066 0.936
Time 3,1 ¼ 0:510 0.943 0.944 0.982 0.939
Gender 3,2 ¼ 0:190 1.983 0.959 2.068 0.957
RI sd.
ﬃﬃﬃﬃﬃﬃ
d33
p ¼ 1:620 1.270 0.931 1.300 0.933
LDL-chol. Targets and
HbA1c targets Cov. RI’s d12 ¼ 0:808 5.054 0.945 5.355 0.949
LDL-chol. targets and
SBP targets Cov. RI’s d13 ¼ 1:218 3.623 0.928 3.678 0.940
HbA1c targets and
SBP targets Cov. RI’s d23 ¼ 1:393 4.660 0.940 4.820 0.944
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Table 16. Simulation study for two time-points with N Subjects ¼ 1000, N random samples ¼ 1000.
Estimation method CPU Time on HPC Factor for CPU: PC vs. HPC CPU Time on PC
ML 0:00:51 1.53 0:01:18
PLp 0:00:11 1.32 0:00:14
PLs, M¼ 5 0:00:11 1.54 0:00:17
PLs, M¼ 10 0:00:07 1.55 0:00:11
PLps, M¼ 5 0:00:02 1.41 0:00:04
PLps, M¼ 10 0:00:01 1.41 0:00:02
Note: Average computation time (hours:minutes:seconds) for the longest subprocess for different estimation methods, the Q ¼ 3
case. ML: maximization of full likelihood; PLp: pairwise modeling; PLs, M ¼ 5: partitioned samples, M ¼ 5; PLs, M ¼ 10: partitioned
samples, M ¼ 10; PLps, M ¼ 5: combined modeling, M ¼ 5; PLps, M ¼ 10: combined modeling, M ¼ 10.
Table 17. Simulation study for different number of time-points with N Subjects ¼ 10,000, N random samples ¼ 200:
MSE and interval coverage for the ML estimation method, for the Q ¼ 3 case.
ML
Two time-points 10 time-points 20 time-points
Outcome Effect Par. 103MSE Int.Cov. 103MSE Int.Cov. 103MSE Int.Cov.
LDL-chol. Int. 1 1,01 ¼ 0:740 1.499 0.955 0.951 0.980 0.819 0.955
Targets Int. 2 1,02 ¼ 0:480 1.838 0.945 0.978 0.970 0.820 0.965
Int. 3 1,03 ¼ 1:580 3.154 0.835 1.055 0.965 0.814 0.955
Time 1,1 ¼ 1:050 1.212 0.940 0.445 0.980 0.298 0.955
Gender 1,2 ¼ 0:450 2.211 0.970 1.561 0.950 1.447 0.945
RI sd.
ﬃﬃﬃﬃﬃﬃ
d11
p ¼ 1:880 6.882 0.440 0.567 0.840 0.300 0.920
HbA1c Int. 1 2,01 ¼ 0:270 2.686 0.875 1.563 0.925 1.217 0.945
Targets Int. 2 2,02 ¼ 2:610 11.62 0.575 1.806 0.925 1.230 0.945
Time 2,1 ¼ 1:040 1.832 0.885 0.867 0.955 0.386 0.930
Gender 2,2 ¼ 0:090 2.345 0.985 2.097 0.960 1.963 0.965
RI sd.
ﬃﬃﬃﬃﬃﬃ
d22
p ¼ 2:150 19.62 0.085 1.434 0.675 0.700 0.835
SBP Int. 1 3,01 ¼ 0:190 1.507 0.910 0.829 0.950 0.646 0.955
Targets Int. 2 3,02 ¼ 1:380 1.734 0.925 0.826 0.960 0.619 0.965
Int. 3 3,03 ¼ 3:700 4.061 0.915 1.059 0.950 0.770 0.940
Time 3,1 ¼ 0:510 0.934 0.955 0.526 0.965 0.245 0.950
Gender 3,2 ¼ 0:190 1.820 0.955 1.187 0.965 1.076 0.955
RI sd.
ﬃﬃﬃﬃﬃﬃ
d33
p ¼ 1:620 2.932 0.755 0.341 0.875 0.245 0.900
LDL-chol. targets and
HbA1c targets Cov. RI’s d12 ¼ 0:808 7.105 0.895 2.564 0.940 2.340 0.940
LDL-chol. targets and
SBP Targets Cov. RI’s d13 ¼ 1:218 5.247 0.840 1.521 0.965 1.242 0.955
HbA1c targets and
SBP targets Cov. RI’s d23 ¼ 1:393 8.650 0.805 2.272 0.925 1.804 0.940
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values, we can fairly compare the computation times. The results are summarized in Table 6. The
algorithm for the full likelihood method, ML, converged in 7min 13 s. As with the pseudo-likelihood
methods, the submodeling processes can be regarded as independent from one another and they can
run in parallel on diﬀerent computers. For example, for PLp, the computation time decreases to
1min 23 s, i.e. the longest computation time among all parallel processes. A quite similar ﬁnding is
obtained for PLs : 1min 21 s. But for PLps, we only need 20 s, a spectacular gain in speed. This clearly
illustrates that the main advantage of the pairwise model ﬁtting of partitioned data sets is that it
allows ﬁtting complex models to large data sets, which in some cases would not be feasible with
standard model ﬁtting procedures by maximum likelihood.
In addition, to investigate the validity of the classical ML method as well as that of the alternative
PL methods, a series of simulations were performed. The selected scenario was similar to the diabetes
study where in the univariate POMM model, for every response, only time and covariate gender were
included. The simulations were performed for 1000 subjects measured longitudinally on two time-
points with three outcomes and 1000 random samples; these were generated from the joint population
of three ordinal variables with the covariance structure as discussed above. The correlations were set to
the following magnitudes: 0.2, 0.4, and 0.4. For numerical integration, Q¼ 3 was used. For PLs and
Table 18. Simulation study for different number of time-points with N Subjects ¼ 10,000, N random samples ¼ 200:
MSE and interval coverage for the PLp estimation method, for the Q¼ 3 case.
PLp
Two time-points 10 time-points 20 time-points
Outcome Effect Par. 103MSE Int.Cov. 103MSE Int.Cov. 103MSE Int.Cov.
LDL-chol. Int. 1 1,01 ¼ 0:740 1.501 0.955 0.952 0.975 0.834 0.960
Targets Int. 2 1,02 ¼ 0:480 1.862 0.940 0.979 0.970 0.834 0.965
Int. 3 1,03 ¼ 1:580 3.223 0.840 1.058 0.965 0.831 0.955
Time 1,1 ¼ 1:050 1.216 0.940 0.446 0.980 0.299 0.955
Gender 1,2 ¼ 0:450 2.219 0.970 1.570 0.950 1.470 0.940
RI sd.
ﬃﬃﬃﬃﬃﬃ
d11
p ¼ 1:880 7.232 0.380 0.592 0.825 0.308 0.920
HbA1c Int. 1 2,01 ¼ 0:270 2.757 0.870 1.579 0.925 1.254 0.940
Targets Int. 2 2,02 ¼ 2:610 12.00 0.540 1.829 0.925 1.271 0.945
Time 2,1 ¼ 1:040 1.843 0.880 0.866 0.955 0.387 0.935
Gender 2,2 ¼ 0:090 2.342 0.985 2.108 0.960 2.023 0.960
RI sd.
ﬃﬃﬃﬃﬃﬃ
d22
p ¼ 2:150 20.47 0.055 1.524 0.640 0.730 0.815
SBP Int. 1 3,01 ¼ 0:190 1.511 0.905 0.839 0.950 0.665 0.955
Targets Int. 2 3,02 ¼ 1:380 1.820 0.910 0.836 0.960 0.640 0.955
Int. 3 3,03 ¼ 3:700 4.350 0.870 1.072 0.945 0.794 0.935
Time 3,1 ¼ 0:510 0.943 0.955 0.527 0.965 0.246 0.950
Gender 3,2 ¼ 0:190 1.820 0.955 1.203 0.965 1.102 0.955
RI sd.
ﬃﬃﬃﬃﬃﬃ
d33
p ¼ 1:620 3.379 0.685 0.360 0.865 0.250 0.895
LDL-chol. targets and
HbA1c targets Cov. RI’s d12 ¼ 0:808 6.839 0.900 2.544 0.945 2.359 0.930
LDL-chol. targets and
SBP targets Cov. RI’s d13 ¼ 1:218 5.426 0.825 1.519 0.965 1.246 0.955
HbA1c targets and
SBP targets Cov. RI’s d23 ¼ 1:393 9.179 0.795 2.286 0.935 1.808 0.940
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PLps, the data were split into M¼ 5 and M¼ 10 independent subsamples. Further, the precision of
each parameter for the ML and PL methods was assessed using mean square error (MSE) and interval
coverage. Finally, all results are summarized in Tables 13–15 (see Appendix 5). When comparing
outcomes of all methods, we observe that MSE is slightly higher for some category-speciﬁc intercepts,
for the non-repeated measured covariate, and for some components of the covariance matrix. Almost
for all methods, the interval coverage is high for all ﬁxed eﬀects, and also for the covariances of the
random eﬀects, but slightly lower for the standard deviations of the random eﬀects. The exception is
with the PLs method with M¼ 10: here, the magnitude of the interval coverage is overall lower
compared to other methods. The low coverage was due to the small sample size of only 100
subjects when the asymptotic distribution of parameter estimates could not be reached. Also, from
the 1000 generated random samples, for PLs given M¼ 10, 77 ﬁtted models and for PLps given
M¼ 10, 28 ﬁtted models did not converge and an additional number of random samples was
simulated to reach the required number of 1000.
Because the simulations were performed on HPC, in order to estimate the computation time required
by the originally used computational platform, we re-ran several of them on that platform. The results
are shown in Table 16 of Appendix 5. Again, the PLps method turns out to be the fastest.
Table 19. Simulation study for different number of time-points with N Subjects ¼ 10,000, N random samples ¼ 200:
MSE and interval coverage for the PLs M ¼ 5 estimation method, for the Q ¼ 3 case.
PLs, M¼ 5
Two time-points 10 time-points 20 time-points
Outcome Effect Par. 103MSE Int.Cov. 103MSE Int.Cov. 103MSE Int.Cov.
LDL-chol. Int. 1 1,01 ¼ 0:740 1.500 0.950 0.957 0.970 0.844 0.960
Targets Int. 2 1,02 ¼ 0:480 1.830 0.940 0.983 0.970 0.844 0.965
Int. 3 1,03 ¼ 1:580 3.057 0.845 1.059 0.965 0.840 0.955
Time 1,1 ¼ 1:050 1.202 0.935 0.446 0.980 0.298 0.950
Gender 1,2 ¼ 0:450 2.209 0.975 1.562 0.950 1.482 0.945
RI sd.
ﬃﬃﬃﬃﬃﬃ
d11
p ¼ 1:880 6.808 0.430 0.596 0.820 0.317 0.900
HbA1c Int. 1 2,01 ¼ 0:270 2.662 0.875 1.571 0.925 1.253 0.940
Targets Int. 2 2,02 ¼ 2:610 11.05 0.590 1.804 0.925 1.263 0.945
Time 2,1 ¼ 1:040 1.780 0.880 0.869 0.955 0.387 0.930
Gender 2,2 ¼ 0:090 2.343 0.985 2.129 0.965 2.032 0.965
RI sd.
ﬃﬃﬃﬃﬃﬃ
d22
p ¼ 2:150 19.24 0.085 1.477 0.650 0.728 0.815
SBP Int. 1 3,01 ¼ 0:190 1.513 0.910 0.833 0.950 0.654 0.955
Targets Int. 2 3,02 ¼ 1:380 1.706 0.940 0.829 0.965 0.627 0.970
Int. 3 3,03 ¼ 3:700 3.839 0.915 1.056 0.950 0.776 0.940
Time 3,1 ¼ 0:510 0.937 0.955 0.526 0.965 0.244 0.950
Gender 3,2 ¼ 0:190 1.828 0.955 1.191 0.965 1.089 0.950
RI sd.
ﬃﬃﬃﬃﬃﬃ
d33
p ¼ 1:620 2.908 0.760 0.356 0.870 0.255 0.890
LDL-chol. targets and
HbA1c targets Cov. RI’s d12 ¼ 0:808 7.022 0.895 2.560 0.940 2.340 0.940
LDL-chol. targets and
SBP targets Cov. RI’s d13 ¼ 1:218 5.158 0.840 1.538 0.965 1.253 0.960
HbA1c targets and
SBP targets Cov. RI’s d23 ¼ 1:393 8.372 0.810 2.273 0.930 1.809 0.945
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To investigate in depth the said problem with interval coverage, a limited set of simulations in the
same settings as before but now with a much larger number of subjects (10,000) was performed using
HPC. For this case, only 200 random samples were generated. The results for all methods are listed
in Tables 17–22 (see Appendix 5). For PLs, M¼ 10 (Table 20, second column) we observe that the
interval coverage is in general higher for the ﬁxed eﬀects when the subsamples include a larger
number of subjects. However, for all methods, the interval coverage of the standard deviation of
some random eﬀects is dramatically low. When increasing the number of time-points over which the
subject was measured, the interval coverage increased to a reasonably high value. Hence, in order to
reach the asymptotic distribution of the estimates of all components of the covariance matrix, a
larger number of time-points for the subject measurements are required.
7 Concluding remarks
Pairwise and partition pseudo-likelihood ﬁtting were applied to multivariate joint proportional odds
mixed models. In addition, a new combined method of pairwise modeling of subsamples was
introduced. Partitioning here was done into independent subsamples, where each subsample
Table 20. Simulation study for different number of time-points with N Subjects ¼ 10,000, N random samples ¼ 200:
MSE and interval coverage for PLs M¼ 10 estimation method, for the Q¼ 3 case.
PLs, M¼ 10
Two time-points 10 time-points 20 time-points
Outcome Effect Par. 103MSE Int.Cov. 103MSE Int.Cov. 103MSE Int.Cov.
LDL-chol. Int. 1 1,01 ¼ 0:740 1.509 0.950 0.955 0.975 0.845 0.950
Targets Int. 2 1,02 ¼ 0:480 1.823 0.940 0.980 0.970 0.845 0.965
Int. 3 1,03 ¼ 1:580 2.956 0.845 1.054 0.965 0.842 0.955
Time 1,1 ¼ 1:050 1.190 0.935 0.447 0.980 0.299 0.945
Gender 1,2 ¼ 0:450 2.197 0.975 1.564 0.955 1.494 0.945
RI sd.
ﬃﬃﬃﬃﬃﬃ
d11
p ¼ 1:880 6.672 0.465 0.628 0.805 0.336 0.895
HbA1c Int. 1 2,01 ¼ 0:270 2.642 0.875 1.577 0.925 1.263 0.950
Targets Int. 2 2,02 ¼ 2:610 10.38 0.620 1.797 0.925 1.271 0.945
Time 2,1 ¼ 1:040 1.723 0.885 0.874 0.955 0.387 0.935
Gender 2,2 ¼ 0:090 2.331 0.985 2.139 0.965 2.044 0.960
RI sd.
ﬃﬃﬃﬃﬃﬃ
d22
p ¼ 2:150 18.79 0.085 1.539 0.635 0.770 0.800
SBP Int. 1 3,01 ¼ 0:190 1.511 0.915 0.836 0.955 0.658 0.960
Targets Int. 2 3,02 ¼ 1:380 1.666 0.940 0.831 0.960 0.631 0.970
Int. 3 3,03 ¼ 3:700 3.613 0.925 1.061 0.950 0.783 0.940
Time 3,1 ¼ 0:510 0.936 0.955 0.526 0.970 0.245 0.950
Gender 3,2 ¼ 0:190 1.827 0.960 1.192 0.965 1.090 0.955
RI sd.
ﬃﬃﬃﬃﬃﬃ
d33
p ¼ 1:620 2.891 0.765 0.374 0.855 0.267 0.880
LDL-chol. targets and
HbA1c targets Cov. RI’s d12 ¼ 0:808 6.917 0.895 2.594 0.940 2.350 0.940
LDL-chol. targets and
SBP targets Cov. RI’s d13 ¼ 1:218 4.992 0.845 1.550 0.965 1.252 0.960
HbA1c targets and
SBP targets Cov. RI’s d23 ¼ 1:393 8.090 0.830 2.305 0.935 1.834 0.935
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consists of an independent set of patients. The attraction of the methods is that various forms of
partitioning can be done at the same time: (a) rearranging a large set of simultaneously measured
longitudinal sequences into pairs (b) into independent subsets of subjects, (c) splitting the potentially
long longitudinal sequences into shorter subsequences. Clearly, both (a) and (c) lead to dependent
subsamples, for which general pseudo-likelihood inference can be used. Further, as investigated by
Molenberghs et al.,17 the splitting of long longitudinal sequences in (c) into shorter ones strongly
depends on what is practically and numerically feasible. And longer subsequences lead to smaller
losses in eﬃciency.
After comparing the three pseudo-likelihood methods with the one based on full likelihood on the
diabetes data, the following observations were made. First, even for low numbers of quadrature
points (Q¼ 3), the alternative PL methods yield valid estimates with high eﬃciency. The eﬃciency of
the alternative methods was slightly lower for some estimates of the covariance between the random
intercepts, in particular for the combined method. This was also the case for some category-speciﬁc
intercepts.
The big advantage of the alternative methods is their gain in computation time over the full
likelihood method. Even if it would be feasible to apply the full model on all response components,
Table 21. Simulation study for different number of time-points with N Subjects ¼ 10,000, N random samples ¼ 200:
MSE and interval coverage for PLps M¼ 5 estimation method, for the Q¼ 3 case.
PLps, M¼ 5
Two time-points 10 time-points 20 time-points
Outcome Effect Par. 103MSE Int.Cov. 103MSE Int.Cov. 103MSE Int.Cov.
LDL-chol. Int. 1 1,01 ¼ 0:740 1.501 0.955 0.955 0.970 0.843 0.960
Targets Int. 2 1,02 ¼ 0:480 1.849 0.940 0.981 0.970 0.843 0.965
Int. 3 1,03 ¼ 1:580 3.116 0.835 1.058 0.965 0.839 0.955
Time 1,1 ¼ 1:050 1.205 0.935 0.446 0.980 0.299 0.950
Gender 1,2 ¼ 0:450 2.216 0.975 1.566 0.950 1.481 0.945
RI sd.
ﬃﬃﬃﬃﬃﬃ
d11
p ¼ 1:880 7.150 0.380 0.619 0.810 0.325 0.895
HbA1c Int. 1 2,01 ¼ 0:270 2.736 0.870 1.579 0.925 1.262 0.940
Targets Int. 2 2,02 ¼ 2:610 11.43 0.570 1.817 0.925 1.275 0.945
Time 2,1 ¼ 1:040 1.788 0.880 0.871 0.955 0.387 0.940
Gender 2,2 ¼ 0:090 2.340 0.985 2.124 0.960 2.042 0.965
RI sd.
ﬃﬃﬃﬃﬃﬃ
d22
p ¼ 2:150 20.11 0.060 1.565 0.630 0.759 0.795
SBP Int. 1 3,01 ¼ 0:190 1.516 0.915 0.836 0.955 0.664 0.955
Targets Int. 2 3,02 ¼ 1:380 1.786 0.920 0.834 0.960 0.637 0.965
Int. 3 3,03 ¼ 3:700 4.086 0.890 1.064 0.950 0.788 0.940
Time 3,1 ¼ 0:510 0.945 0.950 0.526 0.965 0.245 0.950
Gender 3,2 ¼ 0:190 1.826 0.955 1.203 0.960 1.105 0.955
RI sd.
ﬃﬃﬃﬃﬃﬃ
d33
p ¼ 1:620 3.358 0.690 0.376 0.855 0.259 0.885
LDL-chol. targets and
HbA1c targets Cov. RI’s d12 ¼ 0:808 6.755 0.900 2.538 0.945 2.350 0.940
LDL-chol. targets and
SBP targets Cov. RI’s d13 ¼ 1:218 5.329 0.830 1.529 0.960 1.254 0.960
HbA1c targets and
SBP targets Cov. RI’s d23 ¼ 1:393 8.898 0.790 2.284 0.935 1.813 0.945
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one could still prefer to proceed with one of the pseudo-likelihood methods. Indeed, as our example
shows for only three components, we can achieve a signiﬁcant reduction in computation time: from
7min 13 s to only 20 s using the combined approach. This was due to the fact that the submodels
could run in parallel. When confronted with time restrictions, it is therefore recommended to
consider pairwise ﬁtting of independent partitions.
Currently, as large data sets are often collected and stored, the number of response outcomes
increases rapidly. When ﬁtting the full model becomes unrealistic, pseudo-likelihood methods could
oﬀer a solution. Also, as the subprocesses could run in a parallel, the required computation time
becomes feasible. When modeling, the main interest is with the estimation and inference for the ﬁxed
eﬀects, properly accounting for dependencies in the data. At the same time, the association
parameters may be of, perhaps secondary, interest as well. The pairwise setting is the minimal
one that allows identiﬁcation of all the parameters. Evidently, one could consider tripels or
higher tupels as well, but this will arguably lead to minimal increase of eﬃciency, while
drastically increase computational burden.
If we increase the number of quadrature points to achieve a better approximation, it is not
unexpected that the computation time will increase as well. For example, for Q¼ 15, the
Table 22. Simulation study for different number of time-points with N Subjects ¼ 10,000, N random samples ¼ 200:
MSE and interval coverage for PLps M¼ 10 estimation method, for the Q¼ 3 case.
PLps, M¼10
Two time-points 10 time-points 20 time-points
Outcome Effect Par. 103MSE Int.Cov. 103MSE Int.Cov. 103MSE Int.Cov.
LDL-chol. Int. 1 1,01 ¼ 0:740 1.509 0.950 0.954 0.970 0.843 0.955
Targets Int. 2 1,02 ¼ 0:480 1.841 0.945 0.979 0.970 0.844 0.965
Int. 3 1,03 ¼ 1:580 3.010 0.845 1.054 0.965 0.840 0.955
Time 1,1 ¼ 1:050 1.192 0.935 0.448 0.980 0.299 0.950
Gender 1,2 ¼ 0:450 2.202 0.975 1.567 0.955 1.488 0.940
RI sd.
ﬃﬃﬃﬃﬃﬃ
d11
p ¼ 1:880 7.006 0.390 0.651 0.800 0.344 0.890
HbA1c Int. 1 2,01 ¼ 0:270 2.713 0.870 1.584 0.925 1.270 0.945
Targets Int. 2 2,02 ¼ 2:610 10.76 0.590 1.808 0.925 1.280 0.945
Time 2,1 ¼ 1:040 1.732 0.885 0.875 0.955 0.387 0.935
Gender 2,2 ¼ 0:090 2.325 0.985 2.134 0.965 2.048 0.955
RI sd.
ﬃﬃﬃﬃﬃﬃ
d22
p ¼ 2:150 19.69 0.075 1.631 0.585 0.802 0.780
SBP Int. 1 3,01 ¼ 0:190 1.514 0.915 0.838 0.955 0.669 0.955
Targets Int. 2 3,02 ¼ 1:380 1.739 0.920 0.835 0.965 0.643 0.965
Int. 3 3,03 ¼ 3:700 3.817 0.905 1.066 0.950 0.795 0.940
Time 3,1 ¼ 0:510 0.943 0.950 0.526 0.965 0.245 0.945
Gender 3,2 ¼ 0:190 1.824 0.960 1.201 0.960 1.108 0.950
RI sd.
ﬃﬃﬃﬃﬃﬃ
d33
p ¼ 1:620 3.344 0.700 0.397 0.845 0.273 0.875
LDL-chol. targets and
HbA1c targets Cov. RI’s d12 ¼ 0:808 6.647 0.895 2.563 0.950 2.361 0.940
LDL-chol. targets and
SBP targets Cov. RI’s d13 ¼ 1:218 5.144 0.840 1.539 0.960 1.256 0.960
HbA1c targets and
SBP targets Cov. RI’s d23 ¼ 1:393 8.605 0.810 2.321 0.925 1.839 0.940
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implementation of the full likelihood model for the diabetes example will take more than 10 h,
whereas the combined method needs only 4min (see Appendix 4, Table 11). Hence, the gain in
computation time becomes even more relevant. When inspecting Tables 8 and 9 for Q¼ 15, we
observe a small loss in quality for a few estimates, similar to Q¼ 3. From Table 10, we can conclude
that the estimates of the correlations are lower for Q=15 than for Q=3, but for the PLs and PLps
methods they are still closer to the full likelihood method than for the PLp method.
The SAS code developed for the combined method is available from the authors’ website.
From the simulation study, we can conclude that all PL methods yield quite a high precision for
the ﬁxed eﬀects, when taking into account that the data are not split into small subsamples for the
PLs and PLps methods. To reach asymptotic normality for the parameter estimates of all
components of the covariance matrix, a larger number of time-points for the subject
measurements are required.
The longitudinal and hierarchical settings are similar to those of the meta-analysis. Hence, the
developed methodology can be easily and eﬀectively applied in meta-analysis.
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Appendix
1. An asymptotic normal distribution of parameters in case of pairwise modeling
An asymptotic multivariate distribution for h^ isﬃﬃﬃﬃ
N
p
ðh^ hÞ  Nð0, J1KJ1Þ
where J is a block diagonal matrix with blocks Jpp and K a symmetric matrix containing blocks
Kpq
Jpp ¼  1
N
XN
i¼1
E
@2lpi
@hp@h
0
p
 !
,
Kpq ¼ 1
N
XN
i¼1
E
@lpi
@hp
@lqi
@h0q
 !
,
with p, q ¼ 1, . . . ,LðL 1Þ=2.
2. An asymptotic normal distribution of parameters in case of partitioned samples
In case of independent subsamples, blocks Jm and Km (m ¼ 1, . . . ,M) can be regarded as a
simpliﬁcation of the blocks of Appendix 1. They are equal up to the sign
Jm ¼  1
n
Xn
i¼1
E
@2lmi
@hm@h
0
m

 
¼ 1
n
Xn
i¼1
E
@lmi
@hm
@lmi
@h0m

 
¼ Km:
The covariance of
ﬃﬃﬃﬃ
N
p
h^ corresponds to the matrix product J1KJ1 ¼ J1. The asymptotic
distribution for the overall averaged vector of parameter estimators can be expressed as followsﬃﬃﬃﬃ
N
p
ðh^  hÞ ¼
ﬃﬃﬃﬃ
N
p
ðA0h^ A0hÞ  Nð0, M  A0J1AÞ
with
A ¼ 1
M
ðI, I, . . . , IÞ:
3. Asymptotic relative eﬃcency (ARE) for maximum likelihood and pseudo-likelihood methods
with quadrature points Q¼ 3 in approximate integration
4. Results for Q¼ 15 quadrature points in approximate integration
5. Simulation study
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